$NASC

NASCENT PHARMA HOLDINGS

Patent owners and lessors · Pink Limited

0.008 -52.81% as of 10/28/2026, 3:38:13 PM · delayed

Sentiment

BULLISH BEARISH

No open positions yet.

No threads yet for $NASC. Be the first to post.

Official links

Filings

15-12G Wed Jul 16 2025 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
NT 10-K Fri Mar 28 2025 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
EFFECT Fri Jan 24 2025 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
POS AM Mon Jan 13 2025 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
10-Q Tue Nov 19 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View
SC 13G/A Thu Nov 14 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
NT 10-Q Wed Nov 13 2024 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
8-K Mon Oct 28 2024 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View

All filings

Timeline

revenue 9/21/2026 Revenue reported: $2.2M, year ended Dec 31, 2023
revenue 9/21/2026 Revenue reported: $6.7M, year ended Dec 31, 2022
revenue 9/21/2026 Revenue reported: $4.6M, year ended Dec 31, 2021
revenue 9/21/2026 Revenue reported: $1.7M, year ended Dec 31, 2020
revenue 9/21/2026 Revenue reported: $2.3M, year ended Dec 31, 2019
revenue 9/21/2026 Revenue reported: $669K, year ended Dec 31, 2018
revenue 9/21/2026 Revenue reported: $123K, year ended Dec 31, 2017
revenue 9/21/2026 Revenue reported: $15K, quarter ended Sep 30, 2024
revenue 9/21/2026 Revenue reported: $272K, quarter ended Jun 30, 2024
revenue 9/21/2026 Revenue reported: $317K, quarter ended Mar 31, 2024

Company reliability

–

No resolved statements yet.

Revenue

Quarterly

Sep 2024 $15K
Jun 2024 $272K
Mar 2024 $317K
Dec 2023 $377K derived

Annual

FY 2023 $2.2M
FY 2022 $6.7M
FY 2021 $4.6M

Source: SEC XBRL

CEO compensation

$118K (FY 2023) · 0.1x revenue

Marco Alfonsi (current CEO) - $4.8M total disclosed since 2015

Marco Alfonsi

10-K

Provisional - extracted from filings, not verified.

FY 2022 $626K extracted
FY 2021 $2.7M extracted

Notes & debt

Provisional - extracted from filings, not verified.

IN DEFAULT · $17.9M in arrears (+2 with unknown amounts)
$2.7M matured Jan 31, 2022 12% 10-Q · 2024-11-19

Quote

The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated.
$1.2M matured Jan 31, 2022 10-Q · 2024-11-19

Quote

In May 2021, the Company entered into a convertible promissory note (“ASOF Note II”) with Arena Special Opportunities Fund, LP.
$90K matured Jan 31, 2022 10-Q · 2024-11-19

Quote

In May 2021, the Company entered into a convertible promissory note (“ASOP Note II”) with Arena Special Opportunities Partners I, LP.
$2.3M matured Jan 31, 2022 10-Q · 2024-11-19

Quote

In December 2020, the Company entered into a convertible promissory note (“ASOF Note I”) with Arena Special Opportunities Fund, LP (“ASOF”).
— matured Jan 31, 2022 12% 10-Q · 2024-11-19

Quote

The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated.
$3.9M matured Apr 30, 2022 10-Q · 2024-11-19

Quote

Contemporaneous with the sale of the Note and Warrant to the Investor, Arena Special Opportunities Partners I, L.P. and Arena Special Opportunities Fund, L.P. (collectively, “Arena”), who hold promissory notes with an unpaid principal balance of approximately $3,877,000 which became due on April 30, 2022 (the “Arena Notes”), entered into a Forbearance Agreement with the Company pursuant to which they agreed to forbear from exercising remedies under the Arena Notes until December 31, 2024 provided that the Company does not default on its obligations under the Forbearance Agreement.
$52K matured Dec 31, 2022 10-Q · 2024-11-19

Quote

F- 18 Can B̅ Corp. and Subsidiaries Notes to Consolidated Financial Statements December 31, 2022 and 2021 On January 1, 2022, the Company entered into a convertible promissory note (“Empire Note”) with Empire Properties, LLC (“Empire”).
$1.8M matured Mar 2, 2023 10-Q · 2024-11-19

Quote

On March 2, 2023, the Company completed the sale of a promissory note (the “Note”) in the principal amount of $ 1,823,529 to WOMF pursuant to a Securities Purchase Agreement dated as of February 27, 2023.
$1.0M matured Mar 2, 2023 10-Q · 2024-11-19

Quote

The conversion options contained in the combined note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered derivatives and therefore have been recorded in liabilities as part of the convertible promissory note and not bifurcated.
$52K matured Mar 22, 2023 10-Q · 2024-11-19

Quote

In March 2022, the Company entered into a convertible promissory note (“BL Note”) with Blue Lake Partners, LLC (“BL”).
$350K matured Apr 12, 2023 10-Q · 2024-11-19

Quote

The principal balance outstanding at June 30, 2024 was $ 350,000 In January 2023 the Company entered into a convertible promissory note (“Tysadco Note VI”) with Tysadco Partners, LLC (“Tysadco”).
$58K matured Apr 22, 2023 10-Q · 2024-11-19

Quote

In April 2022, the Company entered into a convertible promissory note (“FM Note”) with Fourth Man, LLC (“FM”).
— matured Apr 22, 2023 12% 10-Q · 2024-11-19

Quote

The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered derivatives and therefore have been recorded in liabilities as part of the convertible promissory note and not bifurcated.
$52K matured Aug 30, 2023 10-Q · 2024-11-19

Quote

In August 2022, the Company entered into a convertible promissory note (“WN”) with Walleye Opportunities Master Fund Ltd. (“WOMF”).
$40K matured Sep 1, 2023 10-Q · 2024-11-19

Holder: FM

Quote

The common stock purchase warrants issued to FM are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the FM Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date.
$67K matured Sep 1, 2023 10-Q · 2024-11-19

Holder: BL

Quote

The common stock purchase warrants issued to BL are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the BL Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date.
$175K matured Sep 30, 2024 16% 10-Q · 2024-11-19

Quote

The promissory note accrues interest at a rate of 16 % per annum and is due within six months or due on demand subsequently to any major funding received by the Company in excess of $ 2,000,000 .
$75K matured Nov 12, 2024 12% 10-Q · 2024-11-19

Quote

On February 13, 2024, the Company completed the sale of a promissory note in the principal amount of $ 75,000 to ClearThink.
$75K matured Nov 29, 2024 12% 10-Q · 2024-11-19

Quote

On February 29, 2024, Can B Corp. (the “Company”) completed the sale of a promissory note in the principal amount of $75,000 to ClearThink Capital Partners, LLC (“ClearThink”).
$3.8M — 10-Q · 2024-11-19

Quote

The Arena Entities collectively hold approximately $3,838,770 aggregate principal amount of Convertible Notes (the “Notes”) issued by the Company.
$15K — 10-Q · 2024-11-19

Holder: ClearThink

Quote

The Initial Note contains and the New Notes will contain a provision which provides that the holder will not be converted if the conversion would result in the holder becoming the beneficial owner of more than 9.99 % of the Company’s outstanding common stock. 17 Can B̅ Corp. and Subsidiaries Condensed Notes to Unaudited Consolidated Financial Statements September 30, 2024 ClearThink Notes The Company issued a convertible note in the principal amount of $ 15,000 to ClearThink Capital Partners, LLC (“ClearThink”) in September 2023 for a purchase price of $ 10,000 .
OTHER ISSUANCES
$156K — 6% 10-Q · 2024-11-19

Quote

WOMF October 2023 Note On October 27, 2023, the Company completed the sale of a promissory note (the “Initial Note”) in the principal amount of $ 156,250 to WOMF pursuant to a Securities Purchase Agreement between the Company and the WOMF (the “Stock Purchase Agreement”).
$458K — 10-Q · 2024-11-19

Quote

The Company’s obligations under the promissory note are secured by a pledge of the Company’s equity interest in Nascent. 18 Can B̅ Corp. and Subsidiaries Condensed Notes to Unaudited Consolidated Financial Statements September 30, 2024 Note 9 – Stockholders’ Equity Preferred Stock Each share of Series A Preferred Stock is convertible into 218 shares of CANB common stock and is entitled to 4,444 votes .
$458K — 10-Q · 2024-11-19

Quote

Related Party Note The Company has entered into a promissory note with Pat Ferro, a co-founder of the Company.
$438K — 10-Q · 2024-11-19

Quote

In May 2023, the Company issued a promissory note to WOMF in the principal amount of $ 437,500 .
$5 — 10-Q · 2024-11-19

Holder: WOMF

Quote

The common stock purchase warrants issued to WOMF are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the WN with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date.
$6 — 10-Q · 2024-11-19

Holder: Alumni

Quote

The common stock purchase warrants issued to Alumni are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the Alumni Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date.
$7 — 10-Q · 2024-11-19

Quote

In addition, the ASOP convertible promissory note was issued with 26,228 common stock warrants.
$7 — 10-Q · 2024-11-19

Quote

In addition, the ASOP convertible promissory note was issued with 101,978 common stock warrants.
$7 — 10-Q · 2024-11-19

Quote

In addition, the ASOF convertible promissory note was issued with 8,755 common stock warrants.
$7 — 10-Q · 2024-11-19

Quote

In addition, the ASOP convertible promissory note was issued with 228,419 common stock warrants.
$300K — 10-Q · 2024-11-19

Holder: Arena Special Opportunities Partners I, L.P

Quote

The auction resulted in proceeds of approximately $ 300,000 which were applied to the Company’s obligations under convertible notes held by Arena Special Opportunities Partners I, L.P. and its affiliates.
No notes match this filter.

Top predictors

No resolved predictions on $NASC yet.

Upcoming resolutions

Nothing awaiting resolution.